FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-111484.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.08-111484v1
22/11/3795    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, C.-Y.
Right arrow Articles by Chou, M.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, C.-Y.
Right arrow Articles by Chou, M.-Y.
(The FASEB Journal. 2008;22:3795-3804.)
© 2008 FASEB

Production of multivalent protein binders using a self-trimerizing collagen-like peptide scaffold

Chia-Yu Fan1,*, Chuan-Chuan Huang1,*, Wei-Chun Chiu*, Chun-Chieh Lai{dagger}, Gunn-Guang Liou{dagger}, Hsiu-Chuan Li* and Min-Yuan Chou2,*

* Biomedical Engineering Research Laboratories, Industrial Technology Research Institute, Taiwan; and

{dagger} Division of Molecular and Genomic Medicine, National Health Research Institutes, Taiwan

2Correspondence: Biomedical Engineering Research Laboratories, Industrial Technology Research Institute, Bldg. 53, No 195, Sec. 4, Chung Hsing Rd., Chutung, Hsinchu 310, Taiwan, Republic of China. E-mail: minyuanc{at}itri.org.tw

A class of multivalent protein binders was designed to overcome the limitations of low-affinity therapeutic antibodies. These binders, termed "collabodies," use a triplex-forming collagen-like peptide to drive the trimerization of a heterologous target-binding domain. Different forms of collabody, consisting of the human single-chain variable fragment (scFv) fused to either the N or C terminus of the collagen-like peptide scaffold (Gly-Pro-Pro)10, were stably expressed as soluble secretory proteins in mammalian cells. The collabody consisting of scFv fused to the N terminus of collagen scaffold is present as a homotrimer, whereas it exhibited a mixture of trimer and interchain disulfide-bonded hexamer when cysteine residues were introduced and flanked the scaffold. The collagenous motif in collabody is prolyl-hydroxylated, with remarkable thermal and serum stabilities. The collabody erb_scFv-Col bound to the extracellular domain of epidermal growth factor receptor with a binding strength ~20- and 1000-fold stronger than the bivalent and monovalent counterparts, respectively. The trimeric collagen scaffold does not compromise the functionality of the binding moieties of parental immunoglobulin G (IgG); therefore, it could be applied to fuse other protein molecules to acquire significantly improved targeting-binding strengths.—Fan, C.-Y., Huang, C.-C., Chiu, W.-C., Lai, C.-C., Liou, G.-G., Li, H.-C., and Chou, M.-Y. Production of multivalent protein binders using a self-trimerizing collagen-like peptide scaffold.


Key Words: phage-display • single-chain antibody • EGFR • CD3







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.